ProCyto Labs has successfully licensed its novel ophthalmic formulation to Farmigea, a renowned 75-year-old Italian ophthalmic pharmaceutical company. The agreement was concluded ahead of both patent grant and clinical trials, marking a significant milestone in ProCyto Labs’ translational innovation journey. As a part of this agreement, has undertaken the European patent coverage and secured rights for…